Legal & General Group’s Spero Therapeutics SPRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-1,934
| Closed | -$1K | – | 3484 |
|
|
2022
Q2 | $1K | Sell |
1,934
-647
| -25% | -$335 | ﹤0.01% | 3504 |
|
|
2022
Q1 | $22K | Buy |
2,581
+114
| +5% | +$972 | ﹤0.01% | 3220 |
|
|
2021
Q4 | $40K | Hold |
2,467
| – | – | ﹤0.01% | 3080 |
|
|
2021
Q3 | $45K | Sell |
2,467
-92
| -4% | -$1.68K | ﹤0.01% | 3007 |
|
|
2021
Q2 | $36K | Buy |
2,559
+390
| +18% | +$5.49K | ﹤0.01% | 3066 |
|
|
2021
Q1 | $32K | Sell |
2,169
-8,231
| -79% | -$121K | ﹤0.01% | 2970 |
|
|
2020
Q4 | $202K | Buy |
10,400
+575
| +6% | +$11.2K | ﹤0.01% | 2417 |
|
|
2020
Q3 | $110K | Sell |
9,825
-700
| -7% | -$7.84K | ﹤0.01% | 2461 |
|
|
2020
Q2 | $142K | Buy |
10,525
+8,856
| +531% | +$119K | ﹤0.01% | 2438 |
|
|
2020
Q1 | $13K | Sell |
1,669
-455
| -21% | -$3.54K | ﹤0.01% | 3095 |
|
|
2019
Q4 | $20K | Hold |
2,124
| – | – | ﹤0.01% | 3190 |
|
|
2019
Q3 | $23K | Buy |
2,124
+650
| +44% | +$7.04K | ﹤0.01% | 3092 |
|
|
2019
Q2 | $17K | Hold |
1,474
| – | – | ﹤0.01% | 3260 |
|
|
2019
Q1 | $19K | Buy |
1,474
+455
| +45% | +$5.87K | ﹤0.01% | 3112 |
|
|
2018
Q4 | $6K | Hold |
1,019
| – | – | ﹤0.01% | 3324 |
|
|
2018
Q3 | $11K | Hold |
1,019
| – | – | ﹤0.01% | 3313 |
|
|
2018
Q2 | $15K | Hold |
1,019
| – | – | ﹤0.01% | 3252 |
|
|
2018
Q1 | $14K | Hold |
1,019
| – | – | ﹤0.01% | 3176 |
|
|
2017
Q4 | $12K | Buy |
+1,019
| New | +$12K | ﹤0.01% | 3220 |
|